Singapore, May 6 -- The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) has announced a research partnership with MitoQ New Zealand to examine the potential role of MitoQ(R) (mitoquinol mesylate), a mitochondria-targeted antioxidant, in supporting healthy ageing.

Building on existing scientific literature, the partnership aims to generate evidence on whether MitoQ(R) can slow or improve markers of biological ageing and support longevity potential. The joint study will also evaluate the effectiveness of biological ageing clocks in assessing health supplements and other interventions more rapidly than conventional long-term clinical trials.

The partnership will enable NUS Medicine researchers to evaluate e...